• 2015 International Research Symposium

    CurePSP 2015 International Research Symposium will be held November 5 - 7, 2015. The symposium highlights research by CurePSP grantees and is open to all researchers interested in clinical and basic studies of PSP, CBD and related tauopathies. Registrants are invited to submit a poster for the event – deadline for abstract submissions is October 1, 2015. Register today!

  • Patient Profile: Prime of Life

    Share the Gervais family's journey, and see how they cope with a PSP diagnosis.

  • Multiple Ascending Dose Study of BMS-986168 in PSP Patients

    CURRENTLY RECRUITING. The purpose of this study is to evaluate the safety and tolerability of multiple ascending intravenous infusions of BMS-986168 and to assess the pharmacodynamics of BMS-986168 on cerebrospinal fluid (CSF) extracellular tau (eTau) concentrations in patients with progressive supranuclear palsy (PSP). Multiple sites: Alabama, California, Florida, Maryland, Minnesota, New Jersey, New York, Pennsylvania, and Texas.

  • Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

    CURRENTLY RECRUITING. To participate, contact the study coordinator directly: Mary Koestler, RN PhD CCRC; University of California, San Francisco, Phone: 415-476-0661; Email: